San Diego, CA, United States of America

Daniel Cashion


 

Average Co-Inventor Count = 15.6

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovations of Daniel Cashion

Introduction

Daniel Cashion is an accomplished inventor based in San Diego, California, known for his contributions in the field of chemistry and pharmaceuticals. With a total of five patents to his name, Cashion has made significant advancements that have the potential to improve treatments and compositions in various medical applications.

Latest Patents

Among his latest innovations, Cashion has developed substituted diaminopyrimidyl compounds. These compounds are characterized by unique structures that showcase their potential in therapeutic applications. His research highlights the synthesis and utilization of these compounds, focusing on their compositions and associated methods of treatment.

Career Highlights

Cashion has had a dynamic career, having worked at notable companies such as Signal Pharmaceuticals and Merck Sharp & Dohme Corporation. His experiences in these well-regarded organizations have greatly enriched his expertise and have provided him with a platform to develop and patent his innovative ideas.

Collaborations

Throughout his career, Daniel Cashion has collaborated with other professionals, including Patrick Papa and Brian Edwin Cathers. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

In summary, Daniel Cashion is a key player in the realm of pharmaceutical innovation. With his impressive patent portfolio and collaborative spirit, he continues to contribute to advancements that hold promise for future medical treatments. His work not only showcases his ingenuity but also his commitment to improving healthcare through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…